UBS O'Connor’s FTAC Hera Acquisition Corp. Class A Ordinary Shares HERA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-471,086
Closed -$4.77M 828
2022
Q4
$4.77M Sell
471,086
-4,610
-1% -$46.1K 0.09% 179
2022
Q3
$4.72M Sell
475,696
-47,621
-9% -$470K 0.05% 267
2022
Q2
$5.13M Hold
523,317
0.05% 288
2022
Q1
$5.12M Buy
523,317
+9,223
+2% +$89.9K 0.06% 254
2021
Q4
$5.02M Buy
514,094
+13,768
+3% +$135K 0.05% 252
2021
Q3
$4.87M Hold
500,326
0.04% 298
2021
Q2
$4.88M Buy
+500,326
New +$4.89M 0.04% 245

UBS O'Connor's HERA Position: Q1 2023 in Review

UBS O'Connor sold out of FTAC Hera Acquisition Corp. Class A Ordinary Shares (HERA) in Q1 2023, closing a stake of 471,086 shares — an estimated $4.77M sold.

UBS O'Connor first reported a position in HERA in Q2 2021 and held it in 7 quarters. The position peaked at $5.13M in Q2 2022. 0 funds tracked by Wall St. Rank hold HERA as of Q1 2023.

  • UBS O'Connor reported no remaining FTAC Hera Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 471,086 FTAC Hera Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $4.77M.
  • UBS O'Connor first reported a position in FTAC Hera Acquisition Corp. Class A Ordinary Shares in Q2 2021 and held it in 7 quarters.
  • UBS O'Connor's FTAC Hera Acquisition Corp. Class A Ordinary Shares position peaked at $5.13M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held FTAC Hera Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.